BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15007271)

  • 21. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
    Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
    Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy.
    Sofue K; Arai Y; Shimada K; Takeuchi Y; Kobayashi T; Satake M; Sugimura K
    Br J Surg; 2014 Aug; 101(9):1122-8. PubMed ID: 24920297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival--a European single center experience.
    Capussotti L; Muratore A; Amisano M; Polastri R; Bouzari H; Massucco P
    Eur J Surg Oncol; 2005 Nov; 31(9):986-93. PubMed ID: 15936169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.
    Capussotti L; Muratore A; Massucco P; Ferrero A; Polastri R; Bouzari H
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S64-8. PubMed ID: 14762842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right portal embolization before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein: a prospective study.
    Tsuge H; Mimura H; Kawata N; Orita K
    Surg Laparosc Endosc; 1994 Aug; 4(4):258-63. PubMed ID: 7952434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Portal vein embolization preparation for major hepatic resection: a new standard in liver surgery].
    Uhl M; Euringer W; Makowiec F; Adam U; Schneider A; Langer M
    Rofo; 2007 Jan; 179(1):31-7. PubMed ID: 17203441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic resections for hepatocellular carcinoma and cirrhosis].
    Frangov T; Gaĭdarski R; Vasilev S; Mladenov L
    Khirurgiia (Sofiia); 2002; 58(1):8-10. PubMed ID: 12515026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases.
    Kosuge T; Makuuchi M; Takayama T; Yamamoto J; Shimada K; Yamasaki S
    Hepatogastroenterology; 1993 Aug; 40(4):328-32. PubMed ID: 8406301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
    Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
    Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
    Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of major hepatic resection for large hepatocellular carcinoma.
    Shuto T; Hirohashi K; Kubo S; Tanaka H; Yamamoto T; Ikebe T; Kinoshita H
    Hepatogastroenterology; 1999; 46(25):413-6. PubMed ID: 10228832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extending the limits for curative liver resections by portal vein embolization.
    Haghighi KS; Glenn D; Gruenberger T; Morris DL
    Int Surg; 2009; 94(1):43-7. PubMed ID: 20099426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of the ICG test with risk factors and postoperative outcomes following hepatic resection.
    Derpapas MK; Contis J; Fragulidis GP; Lykoudis PM; Polymeneas G; Ntourakis S; Voros D
    J BUON; 2013; 18(3):703-7. PubMed ID: 24065486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical margin status in hepatectomy for liver tumors].
    Salloum C; Castaing D
    Bull Cancer; 2008 Dec; 95(12):1183-91. PubMed ID: 19091652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of liver transplantation in combined hepatocellular and cholangiocellular carcinoma: a case series.
    Wu D; Shen ZY; Zhang YM; Wang J; Zheng H; Deng YL; Pan C
    BMC Cancer; 2015 Apr; 15():232. PubMed ID: 25886479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.